Kaisheng Liu

Prof. Kaisheng Liu

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
FYFangjun Yu
Fangjun Yu
ZWZhigang Wang
Zhigang Wang
TZTianpeng Zhang
Tianpeng Zhang
XCXun Chen
Xun Chen
HXHaiman Xu
Haiman Xu
BWBao-jian Wu
Bao-jian Wu
The role of intestine clock in energy homeostasis remains elusive. Here we show that mice with Bmal1 specifically deleted in the intestine (Bmal1iKO mice) have a normal phenotype on a chow diet. However, on a high-fat diet (HFD), Bmal1iKO mice are protected against development of obesity and related abnormalities such as hyperlipidemia and fatty livers. These metabolic phenotypes are attributed to impaired lipid resynthesis in the intestine and reduced fat secretion. Consistently, wild-type mice fed a HFD during nighttime (with a lower BMAL1 expression) show alleviated obesity compared to mice fed ad libitum. Mechanistic studies uncover that BMAL1 transactivates the Dgat2 gene (encoding the triacylglycerol synthesis enzyme DGAT2) via direct binding to an E-box in the promoter, thereby promoting dietary fat absorption. Supporting these findings, intestinal deficiency of Rev-erbα, a known BMAL1 repressor, enhances dietary fat absorption and exacerbates HFD-induced obesity and comorbidities. Moreover, small-molecule targeting of REV-ERBα/BMAL1 by SR9009 ameliorates HFD-induced obesity in mice. Altogether, intestine clock functions as an accelerator in dietary fat absorption and targeting intestinal BMAL1 may be a promising approach for management of metabolic diseases induced by excess fat intake.

24 May 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
HLHaizhou Liu
Haizhou Liu
ZZZihan Zhang
Zihan Zhang
YHYi Huang
Yi Huang
WWWene Wei
Wene Wei
SNShufang Ning
Shufang Ning
LZLitu Zhang
Litu Zhang
Aim: We aimed to develop and validate a comprehensive nomogram containing pre-treatment plasma HSP90AA1 to predict the risk of breast cancer onset and metastasis.Methods: We assessed the expression of HSP90s in breast cancer patients using an online database. To verify the results, 677 patients diagnosed with breast cancer and 146 patients with benign breast disease between 2014 and 2019 were selected from our hospital and were divided into cancer risk and metastasis risk cohorts. We focused on HSP90AA1 to elucidate the risks of onset and metastasis in the cohorts.Results: Expression levels of HSP90AA1, HSP90AA2, HSP90AB1, HSP90B1, and TRAP1 were linked to disease progression. Survival analysis using the GEPIA and OncoLnc databases indicated that the upregulation of HSP90AA1 and HSP90AB1 was related to poor overall survival. In the cancer risk cohort, carcinoembryonic antigen (CEA), carbohydrate antigen 153 (CA153), HSP90AA1, T cells%, natural killer cells%, B cells%, neutrophil count, monocyte count, and d-dimer were incorporated into the nomogram. A high Harrell’s concordance index (C-index) value of 0.771 [95% confidence interval (CI), 0.725–0.817] could still be reached in the interval validation. In the metastasis risk cohort, predictors contained in the prediction nomogram included the use of CEA, CA153, HSP90AA1, carbohydrate antigen 125 (CA125), natural killer cells%, B cells%, platelet count, monocyte count, and d-dimer. The C-index was 0.844 (95% CI, 0.801–0.887) and it was well-calibrated. HSP90AA1 raised net clinical benefit of breast cancer onset and metastasis risk prediction nomogram in a range of risk thresholds (5–92%) and (1–90%).Conclusion: Our study revealed that pretreatment plasma HSP90AA1 combined with other markers could conveniently predict the risk of breast cancer onset and metastasis.

21 December 2011 in The Journal of Antibiotics
Verified
Journal Article
Closed access
FHFei He
Fei He
YSYu-Lin Sun
Yu-Lin Sun
KLKaisheng Liu
Kaisheng Liu
XZXiao-Yong Zhang
Xiao-Yong Zhang
PQPei-Yuan Qian
Pei-Yuan Qian
SQShu-Hua Qi
Shu-Hua Qi

13 September 2013 in Planta Medica
Verified
Journal Article
Closed access
PDF file
YSYu-Lin Sun
Yu-Lin Sun
JBJie Bao
Jie Bao
KLKaisheng Liu
Kaisheng Liu
XZXiao-Yong Zhang
Xiao-Yong Zhang
FHFei He
Fei He
SQShuhua Qi
Shuhua Qi
Two new dihydrothiophene-condensed chromones and a new natural chromone, namely oxalicumones A–C (1–3), respectively, were isolated from a culture broth of a marine-derived fungus, Penicillium oxalicum. The structures of 1–3 and acetylated derivatives of 1 (4–7) were elucidated on the basis of spectroscopic methods and chemical reactions. The absolute configuration of 1 and 2 were established by using the modified Mosher ester method and circular dichroism data of an in situ formed [Rh2(OCOCF3)4] and [Mo2(OAc)4] complex. (R)-MTPA ester of 1 showed cytotoxicity against A375, SW-620, and HeLa carcinoma cell lines with IC50 values of 8.9, 7.8, and 18.4 µM, respectively. Compound 1 displayed cytotoxicity against A375 and SW-620 cell lines with IC50 values of 11.7 and 22.6 µM, respectively. The structure–biological activity relationship of 1 was discussed.

1 May 2012 in Cancer Letters
Verified
Journal Article
Closed access
KLKaisheng Liu
Kaisheng Liu
HLHui Liu
Hui Liu
JQJin-Huan Qi
Jin-Huan Qi
QLQiuyun Liu
Qiuyun Liu
ZLZhong Liu
Zhong Liu
YWYi-Fei Wang
Yi-Fei Wang

23 May 2023 in Journal of Hepatology
Verified
Journal Article
Closed access
MCMin Chen
Min Chen
YLYanke Lin
Yanke Lin
YDYongkang Dang
Yongkang Dang
YXYifei Xiao
Yifei Xiao
FZFugui Zhang
Fugui Zhang
BWBao-jian Wu
Bao-jian Wu